The store will not work correctly when cookies are disabled.
(2R)-2-Amino-3-(methanesulfonamido)-N-[3-(trifluoromethoxy)phenyl]propanamide
ID: ALA4759491
PubChem CID: 135387410
Max Phase: Preclinical
Molecular Formula: C11H14F3N3O4S
Molecular Weight: 341.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)NC[C@@H](N)C(=O)Nc1cccc(OC(F)(F)F)c1
Standard InChI: InChI=1S/C11H14F3N3O4S/c1-22(19,20)16-6-9(15)10(18)17-7-3-2-4-8(5-7)21-11(12,13)14/h2-5,9,16H,6,15H2,1H3,(H,17,18)/t9-/m1/s1
Standard InChI Key: GUDXLGCTHDABJB-SECBINFHSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
23.9820 -8.0913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1571 -8.0913 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.5695 -8.8057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2974 -4.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2963 -5.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0111 -6.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7275 -5.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7247 -4.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0093 -4.3828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5816 -6.0348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8675 -5.6217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1527 -6.0337 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.8681 -4.7967 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.1490 -5.2080 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.4426 -6.0338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1563 -5.6201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8715 -6.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1550 -4.7952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5852 -5.6179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8727 -6.8564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1590 -7.2700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4465 -8.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
10 11 1 0
11 12 1 0
11 13 1 0
11 14 1 0
7 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 6
17 20 1 0
20 21 1 0
21 2 1 0
2 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.31 | Molecular Weight (Monoisotopic): 341.0657 | AlogP: 0.40 | #Rotatable Bonds: 6 |
Polar Surface Area: 110.52 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.26 | CX Basic pKa: 7.23 | CX LogP: 0.45 | CX LogD: 0.22 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -1.46 |
References
1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531] [10.1021/acs.jmedchem.0c01215] |